Open Label, Randomized, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Lobeglitazone and Warfarin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Lobeglitazone (Primary) ; Warfarin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 02 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2014 Status changed to active, no longer recruiting, as per Korean Clinical Trials Register record.
- 10 Dec 2013 New trial record